Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer

Mutation-targeted therapies have had a major impact on the treatment of NSCLC, even for patients with advanced disease. Methods for detecting mutations, key clinical trials of targeted therapy, and the most common toxicities of EGFR and ALK inhibition were discussed at JADPRO Live.

Detalles Bibliográficos
Autores principales: Wakelee, Heather, Waxman, Elizabeth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2018
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333550/
_version_ 1783387567051243520
author Wakelee, Heather
Waxman, Elizabeth S.
author_facet Wakelee, Heather
Waxman, Elizabeth S.
author_sort Wakelee, Heather
collection PubMed
description Mutation-targeted therapies have had a major impact on the treatment of NSCLC, even for patients with advanced disease. Methods for detecting mutations, key clinical trials of targeted therapy, and the most common toxicities of EGFR and ALK inhibition were discussed at JADPRO Live.
format Online
Article
Text
id pubmed-6333550
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-63335502019-02-04 Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer Wakelee, Heather Waxman, Elizabeth S. J Adv Pract Oncol Meeting Reports Mutation-targeted therapies have had a major impact on the treatment of NSCLC, even for patients with advanced disease. Methods for detecting mutations, key clinical trials of targeted therapy, and the most common toxicities of EGFR and ALK inhibition were discussed at JADPRO Live. Harborside Press 2018-04 2018-04-01 /pmc/articles/PMC6333550/ Text en Copyright © 2018, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Meeting Reports
Wakelee, Heather
Waxman, Elizabeth S.
Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
title Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
title_full Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
title_fullStr Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
title_full_unstemmed Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
title_short Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
title_sort advances in the use of targeted therapies in the management of non–small cell lung cancer
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333550/
work_keys_str_mv AT wakeleeheather advancesintheuseoftargetedtherapiesinthemanagementofnonsmallcelllungcancer
AT waxmanelizabeths advancesintheuseoftargetedtherapiesinthemanagementofnonsmallcelllungcancer

Ejemplares similares